Label-Free Small Extracellular Vesicles Capturing Strategy for Lung Cancer Diagnosis and Typing Based on a Natural Polyphenol-Metal Three-Dimensional Network.

Haiyan Wang,Delu Liu,Liyuan Zhang,Xiangpeng Gao,Yangyang Nie,Yanli Liu,Youchao Jia,Mingyuan Yin,Xiaoqiang Qiao

DOI: https://doi.org/10.1021/acs.analchem.2c03283

IF: 7.4

2022-01-01

Analytical Chemistry

Abstract:Small extracellular vesicles (sEVs) have been increasingly recognized as circulating biomarkers and prognosticators for disease diagnosis. However, the clinical applications of sEVs are seriously limited by the lack of a robust and easy scale-up isolation technique. Herein, the feasibility of a polyphenol-metal three-dimensional (3D) network for label-free sEV isolation was explored. As a proof-of-concept, with tannic acid (TA) as the polyphenolic ligand and Fe(III) as the coordinated metal, the TA-Fe(III) 3D network coating mesoporous silica beads (SiO2@BSA@Fe-TA6) was designed and fabricated via a coordination-driven layer-by-layer self-assembly approach. The successful fabrication of SiO2@BSA@Fe-TA6 was validated by Fourier transform infrared spectroscopy, scanning electron microscopy, X-ray photoelectron spectroscopy, and thermogravimetric analysis. With the low-cost TA (as low as US$ 0.18/g) as the probe, SiO2@BSA@Fe-TA6 achieved universal capture toward sEVs in different cells and plasma samples. The capture efficiency reached 85.4 ± 1.5%, which is comparable to the antibody-based capture techniques and significantly higher than the ultracentrifugation (UC) method. The purity of sEVs isolated by SiO2@BSA@Fe-TA6 from the H1299 cell culture supernatant was measured as (1.07 ± 0.14) × 1011 particles/μg, which is 3.1 times higher than that via the UC method. Another important superiority of SiO2@BSA@Fe-TA6 is the facile self-assembly approach, which can harvest a yield of up to grams, allowing simultaneous processing of more than 500 plasma samples. The SiO2@BSA@Fe-TA6-based strategy was further successfully employed to distinguish nonsmall cell lung cancer (NSCLC) and small cell lung cancer (SCLC) with an accuracy of 87.1%. The developed SiO2@BSA@Fe-TA6 is a label-free, universal, low cost, and easy scale-up technique for sEV-based liquid biopsy in lung cancer diagnosis and typing.